Introduction: Noncommunicable diseases (NCDs) include cardiovascular diseases, diabetes, hypertension, stroke, cancer, etc. Such diseases mainly result from lifestyle-related factors, such as unhealthy diet, lack of physical activity, use of tobacco, etc. Changes in lifestyles, behavioral patterns, demographic profile, sociocultural and technological advancements lead to sharp increase in the prevalence of NCDs. These diseases, by and large, can be prevented by making simple changes in the way people live their lives or by simply changing our lifestyle. Aims and objectives: Central Council of Research in Ayurvedic Sciences, Ministry of AYUSH in collaboration with Directorate General of Health Services, Ministry of Health and Family Welfare has implemented and executed a program, viz., Integration of AYUSH (Ayurveda) component with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) program in the identified districts of three states, viz., Bhilwara (Rajasthan), Surendranagar (Gujarat), and Gaya (Bihar), with an aim to cater health care services and to reduce the burden of NCDs by combining the strength of Ayurveda and Yoga. Materials and methods:This program has been implemented on a pilot basis in three districts of the three states at three district hospitals (DHs), 49 community health centers (CHCs), and 183 primary health centers (PHCs) (71 at Gaya, 37 at Surendranagar, and 75 at Bhilwara). In view of etiology of NCDs' pharmacological and nonpharmacological interventions, lifestyle and Yoga have been advocated. Sixteen common Ayurvedic medicines were identified for the prevention and management of the NCDs. Training to human resource was provided through various training programs before implementation. Outcomes:The aforesaid program is successfully functional in 52 centers (49 CHCs and 3 DHs) of all the three identified

Introduction: Polycystic ovary syndrome (PCOS) is characterized by oligo-anovulation, clinical or biochemical hyperandrogenism, and polycystic ovaries. It is a metabolic disorder and around 4 to 9% of women of reproductive age are affected by it.

Background: Computer vision syndrome (CVS), also referred to as digital eye strain, describes a group of eye and vision-related problems that result from prolonged use of a computer, tablet, e-reader, and cell phone. According to Ayurveda, this type of exposure to Tejas (light) along with some unwholesome diet and regimen leads to vitiation of Pitta along with Vata. Aim and objectives:To assess the clinical efficacy of Mahatriphaladya ghritam and Anu taila nasya in CVS. Materials and methods:A prospective, open-label study was carried out at Central Ayurveda Research Institute for Cardiovascular Diseases, New Delhi under Central Council for Research in Ayurvedic Sciences. Sixty-two patients satisfying the selection criteria were enrolled from the outpatient department (OPD) and were administered Nasya (nasal insufflation) with Anu taila in a dose of 8 to 8 drops in the morning for 7 days followed by Akshi tarpana with Mahatriphaladya ghrita for 3 consecutive days in the morning which was repeated at an interval of 15 days. Mahatriphaladya ghrita was also given orally in a dose of 5 mL twice a day with lukewarm water for a total of 42 days. The outcome was assessed by seeing a change in signs and symptoms of CVS assessed by using a visual analog scale (VAS) score. Paired sample t-test was used to compare mean change from baseline to subsequent visits (8th, 26th and 42nd day). A p value of <0.05 was considered significant.Results: A significant (p <0.001) improvement in chief complaints was observed at all subsequent visits and follow up (56th day) as compared to baseline. Statistically highly significant effect (p <0.001) was found in Schirmer's test on completion of treatment as compared to baseline. Conclusion:This study revealed the efficacy of Mahatriphaladya ghrita and Anu taila nasyam in the management of CVS.

No abstract

Introduction: Rheumatoid arthritis (RA) is an autoimmune disease resulting in chronic inflammation of the joints and extra-articular tissues characterized by persistent inflammatory synovitis, usually involving the peripheral joints in a symmetric manner. The disease Amavata described in Ayurveda has similar symptomatology to that of RA. Aims and objectives:To assess the clinical efficacy and safety of Vatari Guggulu, Rasnasaptaka kashaya, and Brihat Saindhavadya taila in patients suffering from RA. Materials and methods:A prospective, open-label multicenter study was carried out at four peripheral centers of the Central Council for Research in Ayurvedic Sciences (CCRAS). A total of 230 patients of RA satisfying the selection criteria were enrolled from the outpatient department (OPD) of these centers and were administered Vatari Guggulu 1.5 gm (3 tablets of 500 mg each) twice daily after food with lukewarm water, and Rasnasaptaka kashaya 15 ml with 1 gm Shunthi churna twice